The neuropathology of Huntington's chorea has been extensively studied (Bruyn, 1968 (Bruyn, , 1973 and is marked by a loss of small cells of the basal ganglia, especially of the caudate nucleus and putamen. The most recent work has been devoted to determining the brain concentrations of neurotransmitters and of the enzymes involved in their formation and catabolism with the aim of elucidating any biochemical changes that may underlie the disease. The levels of dopamine (DA), its principal metabolite homovanillic acid (HVA) , and of tyrosine hydroxylase (TOH) are normal (Yates et al., 1973; Bird and Iversen, 1974; Stahl and Swanson, 1974) . GABA and glutamic acid decarboxylase (GAD) are significantly decreased (McGeer et al., 1973; Perry et al., 1973; Bird and Iversen, 1974; McGeer and McGeer, 1976) . Cholineacetyltransferase (CAT) is markedly reduced and acetylcholinesterase is normal (McGeer et al., 1973; Bird and Iversen, 1974; Aquilonius et al., 1975) . There are no data indicating an alteration in serotonin content or metabolism.
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Accepted 24 December 1976 monoamines in cerebrospinal fluid (CSF) in the hope of establishing an index of metabolic events in the brain from easily accessible material, since the CSF metabolites mostly derive from the catabolism of the brain amines. Thus the levels of HVA and 5-hydroxyindolacetic acid (5HIAA) (Curzon et al., 1972; Chase et al., 1972; Chase, 1973; Mattsson and Persson, 1973; Yates et al., 1973; Buscaino et al., 1975) , of choline (Aquilonius and Sj6strom,1971; Aquilonius et al., 1972) , and of GABA (Glaeser et al., 1975) have been determined in a fairly large number of patients with Huntington's chorea. Although agreement is not absolute, in general these studies indicate low CSF levels of HVA, choline, and GABA, and normal levels of 5HIAA which would suggest reduced metabolic activity of the DA, GABA, and cholinergic pathway.
In examining the possibility that Huntington's chorea may express a generalised alteration of the sympathetic nervous system, the blood level of dopamine-beta-hydroxylase (DBH) activity (whose plasma concentration may be considered an index of sympathetic activity) has also been studied in patients with Huntington's chorea (Wetterberg et al., 1972; Lieberman et al., 1973; Mattsson, 1973; Mattsson et al., 1974) . In fact, it has been suggested that an adrenergic hyperactivity may exist in Huntington's chorea as opposed to the adrenergic hypoactivity of Parkinson's disease (Lieberman et al., 1973) .
We have studied the uptake of DA by the platelets, taking platelets to be an accessible model of neuronal uptake. Aminoff et al. (1974) reported an increase of DA uptake in Huntington's chorea.
Patients and methods
We investigated 15 patients, nine men and six women, aged between 26 and 60 years, with a mean age of 44.3+10.5 years. All patients exhibited the typical symptomatology of Huntington's chorea (choreiform movements of varying severity and dementia) and an autosomal dominant inheritance. Rigidity appearing late in the evolution of the disease was evident in two subjects (DMP and CF) . Furthermore, in one patient (DMP) it was impossible to demonstrate any genetic component. All patients' IQs were rated on the Wechsler-Bellevue scale, and a neuropsychological study of frontal coordination and functions (Girotti et al., Cerebrospinal fluid samples were collected initially 15 days after discontinuation of any previous therapy and again after 20 days of drug treatment.
In both instances sampling was performed at 0900, on fasted patients, who had been recumbent for at least eight hours. CSF was collected in plastic test tubes, immediately frozen at -40°C in liquid nitrogen and then stored at -200C until analysis. A blood sample was collected at the same time for plasma DBH activity and platelet uptake of DA.
HVA and 5HIAA concentrations in CSF were measured according to the procedure described by Korf et al. (1971) . The evaluation of the CSF choline level will be reported in another paper (Ladinsky et al., in press ).
The plasma DBH activity was assayed according to Nagatsu and Udenfriend (1972) , and evaluation of platelet uptake of DA was performed according to Barbeau et al. (1975) . Control values for DBH activity were obtained from 76 healthy volunteers, for platelet DA uptake from 12 normal subjects, and for CSF, HVA, and 5HIAA levels from 12 patients before myelographic examination for a suspected herniated disk.
Results

CLINICAL DATA
The motor performance tests (Table 1) showed considerable difference in the degree of impairment of motor dexterity in our choreic patients: six cases had scores that were close to or only slightly above normal, while another nine cases had very high scores indicating a very bad motor performance. The former were classed as 'fast' and the latter as 'slow'. This observation might well reflect the difference in brain damage between the two groups. In the 583 slow group, the brain damage is greater and the sample more homogeneous, and hence the correlation with motor performance appears to be closer. In the fast group, the brain damage is less severe and greater differentiation of intellectual performance is still possible.
The difference between the two groups was also highly significant for IQ scores.
Length of history was based on the memory of patients and relatives, and is not, therefore, a precise datum-relatives as well as patients are reluctant or slow to detect unwanted movements and so to date the onset of symptoms. It can be safely stated, however, that the length of history was on average greater in the slow group (p =0.05). The IQ and length of history did not correlate in either group and there was no significant difference with regard to age between the two groups.
The effect of treatment with haloperidol 4-6 mg daily was evaluated in the two groups by the tests described above. Statistical analysis shows that the drug was effective only on hyperkinesia in both groups (Tables 2, 3 (Table 5) .
The DA uptake by the platelets was slightly decreased in our patients, but the differences were not statistically significant: the DA uptake for the control subjects was 12.1+-SD 0.9%/O, for the DBH activity was assayed according to Nagatsu and Udenfriend (1972) and is expressed as j,mol/litre/min.
Furthermore it must be emphasised that in a few patients the CSF acid metabolite levels were even lower than before therapy. There was no statistically significant difference in the HVA and 5HIAA levels between the slow and fast groups, and no significant correlation could be demonstrated between the levels of these CSF metabolites and clinical parameters such as age, length of history, severity of the symptoms, and results of the performance tests. The DPA administered to three patients did not provoke any modification in the CSF content of HVA and 5HIAA.
T. Caraceni et al. Student's t test: HVA, P < 0.001; SHIAA, P < 0.001. (Wetterberg et al., 1972; Mattsson et al., 1974; Lieberman et al., 1973) .
The platelet DA uptake observed in our patients is not significantly different from the control values, and this result is not in agreement with the preliminary report of Aminoff et al. (1974) .
The determinations of HVA and 5HIAA in the CSF of our patients yielded information of greater interest. The CSF HVA levels, significantly lowered, agree with the data reported by the majority of workers. Curzon et al. (1972) found significantly reduced HVA values in 15 Huntington's chorea patients, and this reduction was subsequently confirmed by other authors (Chase et al., 1972; Chase, 1973; Buscaino et al., 1975) . Normal HVA values were found only in few cases (Yates et al., 1973; McLellan et al., 1974) , and high values are rather rare (Guilleminault et al., 1973) .
No correlation was generally possible between CSF metabolite levels and the principal clinical features (age, length of history, severity of symptoms, and IQ) either in our cases or in those reported in the literature. However, a positive correlation was found by Yates et al. (1973) between age and acid metabolites levels.
The 5HIAA values have been described as normal by several workers (Chase et al., 1972; Curzon et al., 1972; Chase, 1973; Mattsson and Persson, 1973; Yates et al., 1973; McLellan et al., 1974) ; at variance with their results, the CSF 5HIAA levels in our patients were considerably reduced. In our study the difference from the control group was highly significant (P<O.OO1). Values lower than normal, although not significantly so, have also been reported by Buscaino et al. (1975) . Of some interest could be the marked reduction of CSF HVA and 5HIAA levels in one (CF) of our two patients with rigidity.
The results we obtained with haloperidol treatment are also of undoubted interest: in fact no significant differences in HVA and 5HIAA levels were evident after DA-blocking therapy. Rossum, 1976) , which respond differently to the action of drugs in particular pathological situations, or to the different sensitivity and behaviour of the various DA systems (limbic-tuberoinfundibularnigrostriatal) in the brain.
We would also draw attention to the lack of correlation between the extent of the decrease in CSF metabolite levels and the clinical features of the illness (history, slow and fast groups, grade of hyperkinesia, and so on). We feel that these data are against the hypothesis that in Huntington's chorea there is a specific alteration of the metabolism of a single neurotransmitter. In this connection we would recall that GABA and CAT were found to be greatly reduced in the basal ganglia of patients with this disease (McGeer et al., 1973; Bird and Iversen, 1974; Aquilonius et al., 1975) .
Our data and those reported in the literature seem rather to support the hypothesis that the disease leads to extensive damage of different regions of the brain that are more particularly involved in the metabolism of the catecholamines and other neurotransmitters, such as the caudate nucleus, putamen, and substantia nigra.
As to the possible clinical-biochemical correlations in our patients, taking into account also our division into slow and fast performers, we conclude that the determination of the CSF levels of the acid catabolites of the monoamines is of little value for the purpose of assessing the severity of the disease, its duration, and its various clinical features.
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